Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kyndryl Holdings, Inc. (NYSE: KD) resulting from ...

(ABC 6 News) — Senator Amy Klobuchar paid a visit to Rochester on Monday, using it as a backdrop to stress the importance of supporting research and innovation in healthcare. Klobuchar claims it ...

A novel antiviral targeting the SARS-CoV-2 PLpro protease shows strong efficacy in a mouse model, preventing lung pathology and reducing brain dysfunction. The study provides proof-of-principle ...

Kyndryl Holdings (NYSE:KD) was defended by several analysts after a short report from Gotham City Research sent its shares down 5% on Thursday. "Overall, we do not believe there is a 'smoking gun ...

Like the old IBM, except with an Undisclosed Cost Problem: Part I,” Gotham City Research says that Kyndryl (KD) “manipulates” ...

This collaboration underscores Kyndryl’s focus on leveraging AI to drive innovation and efficiency in its services. Meanwhile, the company has refuted allegations from a short seller report by Gotham ...

Investing.com -- Shares of Kyndryl (NYSE:KD) plunged 10% following a critical report by Gotham City Research, which accused the company of manipulating financial metrics and facing potential cost ...

Meanwhile, the company has refuted allegations from a short seller report by Gotham City Research, which accused Kyndryl of financial manipulation and potential cost pressures. Kyndryl dismissed ...